Author: Carretero Rafael
Publisher: Springer Publishing Company
ISSN: 0093-7711
Source: Immunogenetics, Vol.60, Iss.8, 2008-08, pp. : 439-447
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Despite the potential efficacy of cancer immunotherapy in preclinical studies, it did not show yet significant positive clinical results in humans with only a small number of cancer patients demonstrating objective tumor regression. This poor clinical outcome can be explained by the generation of sophisticated tumor immune escape mechanism, in particular, abnormalities in the expression of HLA class I antigens. We have studied the expression of HLA class I antigens in ten metastatic lesions obtained from a melanoma patient undergoing immunotherapy. Five lesions were obtained after Interferon-alpha-2b treatment and five after autologous vaccination plus BCG (M-VAX). Eight metastases were regressing after immunotherapy while two were progressing. The eight regressing metastases showed high level of HLA class I expression, whereas the two progressing lesions had low levels as measured by real time PCR and immunohistological techniques. These results indicate a strong association between HLA class I expression and progression or regression of the metastatic lesions. Our data support the hypothesis that the level of HLA class I expression is an important parameter of tumor immune escape that needs to be monitored.
Related content
By Rodríguez T. Méndez R. Campo A. Aptsiauri N. Martín J. Orozco G. Pawelec G. Schadendorf D. Ruiz-Cabello F. Garrido F.
Immunogenetics, Vol. 59, Iss. 2, 2007-02 ,pp. :
By Engelmark Malin Beskow Anna Magnusson Jessica Erlich Henry Gyllensten Ulf
Human Molecular Genetics, Vol. 15, Iss. 2, 2006-01 ,pp. :
By Rubio Justin Bahlo Melanie Stankovich Jim Burfoot Rachel Johnson Laura Huxtable Stewart Butzkueven Helmut Lin Ling Taylor Bruce Speed Terence Kilpatrick Trevor Mignot Emmanuel Foote Simon
Immunogenetics, Vol. 59, Iss. 3, 2007-03 ,pp. :
Spontaneously regressing brain lesions in Smith–Lemli–Opitz syndrome
American Journal Of Medical Genetics Part A, Vol. 176, Iss. 2, 2018-02 ,pp. :